Effects of ONO-2506PO in Patients With Alzheimer's Disease

Completed · Phase 2

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.

Key facts

Study ID
NCT00083421
Run by
Ono Pharma USA Inc
People needed
647
Starts
2004-06-01
Expected to finish
2007-07-01
Last updated by the study team
2012-06-13

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.